arrow
Back
D

Daphne Guh

University of British Columbia

35H-index
103Paper Count
7.5KCitation Count
Published Papers 53
Publication Date
errShare
errSave
The Patient Self-Administered Inflammatory Arthritis Detection Study
err2026-05-01
err0
PREAI
errBiln, Norma K.; Bansback, Nick; Black, Charlyn; Shojania, Kam; Guh, Daphne; Harrison, Mark J.
errShare
errSave
Impact of the U.S. 2025 tariff policy on Canadian pharmaceutical exports to the U.S
err2026-02-24
err0
errOAAI
errYufan Hu; Wei Zhang; Daphne Guh; Aslam H. Anis
errShare
errSave
Can patient-reported data improve predictions about who will be a high-need, high-cost patient in British Columbia?
err2025-07-09
err0
PREAI
errLogan Trenaman; Daphne Guh; Stirling Bryan; Kimberlyn McGrail; Mohammad Ehsanul Karim; Rick Sawatzky; Maggie Yu; Marilyn Parker; Kathleen Wheeler; Mark Harrison
errShare
errSave
Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD Countries
err2025-02-25
err0
PREAI
errTam, Alexander C. T.; Badesha, Jasleen; Guh, Daphne P.; Bansback, Nick; Peter, Kevin K.; Hollis, Aidan; Grootendorst, Paul; Bae, Sang-Cheol; Anis, Aslam H.; Zhang, Wei
errShare
errSave
The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis
err2024-06-01
err0
errOAAI
errZhang, Wei; Guh, Daphne P.; Grootendorst, Paul; Hollis, Aidan; Anis, Aslam H.
errShare
errSave
The impact of proposed price regulations on new patented medicine launches in Canada: a retrospective cohort study
err2024-05-26
err0
errOAAI
errZhang, Wei; Sun, Huiying; Guh, Daphne P.; Grootendorst, Paul; Hollis, Aidan; Anis, Aslam H.
errShare
errSave
Quality of life of the Canadian population using the VR-12: population norms for health utility values, summary component scores and domain scores
err2023-11-08
err2
errOAAI
errTrenaman, Logan; Guh, Daphne; Bansback, Nick; Sawatzky, Richard; Sun, Huiying; Cuthbertson, Lena; Whitehurst, David G. T.
errShare
errSave
The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC
err2023-11-01
err0
errOAAI
errDobischok, Sophia; Guh, Daphne; Marchand, Kirsten; MacDonald, Scott; Lock, Kurt; Harrison, Scott; Lajeunesse, Julie; Schechter, Martin T.; Oviedo-Joekes, Eugenia
errShare
errSave
A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research
err2022-01-01
err8
PREAI
errMarchand, Kirsten; Palis, Heather; Guh, Daphne; Lock, Kurt; MacDonald, Scott; Brissette, Suzanne; Marsh, David C.; Harrison, Scott; Schechter, Martin T.; Oviedo-Joekes, Eugenia
errShare
errSave
Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach
err2021-01-01
err4
PREAI
errPalis, Heather; Guh, Daphne; MacDonald, Scott; Harrison, Scott; Brissette, Suzanne; Marsh, David C.; Schechter, Martin T.; Oviedo-Joekes, Eugenia
errShare
errSave
The Impact of Tiered-Pricing Framework on Generic Entry in Canada
err2020-11-16
err6
errOAAI
errZhang, Wei; Sun, Huiying; Guh, Daphne P.; Lynd, Larry D.; Hollis, Aidan; Grootendorst, Paul; Anis, Aslam H.
errShare
errSave
Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment Tool
err2020-02-07
err7
PREAI
errPalis, Heather; Marchand, Kirsten; Beaumont, Scott; Guh, Daphne; Harrison, Scott; MacDonald, Scott; Brissette, Suzanne; Marsh, David C.; Schechter, Martin T.; Oviedo-Joekes, Eugenia
errShare
errSave
Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder
err2019-09-01
err18
errOAAI
errOviedo-Joekes, Eugenia; Palis, Heather; Guh, Daphne; Marsh, David C.; MacDonald, Scott; Harrison, Scott; Brissette, Suzanne; Anis, Aslam H.; Schechter, Martin T.
errShare
errSave
Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods
err2019-06-01
err26
PREAI
errOviedo-Joekes, Eugenia; Palis, Heather; Guh, Daphne; Marchand, Kirsten; Brissette, Suzanne; Harrison, Scott; MacDonald, Scott; Lock, Kurt; Anis, Aslam H.; Marsh, David C.; Schechter, Martin T.
errShare
errSave
Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial
err2018-03-28
err35
PREAI
errBansback, Nick; Guh, Daphne; Oviedo-Joekes, Eugenia; Brissette, Suzanne; Harrison, Scott; Janmohamed, Amin; Krausz, Michael; MacDonald, Scott; Marsh, David C.; Schechter, Martin T.; Anis, Aslam H.
errShare
errSave
Do Biologic Therapies for Rheumatoid Arthritis Offset Treatment-Related Resource Utilization and Cost? A Review of the Literature and an Instrumental Variable Analysis
err2017-07-27
err10
PREAI
errBansback, Nick; Fu, Eric; Sun, Huiying; Guh, Daphne; Zhang, Wei; Lacaille, Diane; Milbers, Katherine; Anis, Aslam H.
errShare
errSave
Safety profile of injectable hydromorphone and diacetylmorphine for longterm severe opioid use disorder
err2017-07-01
err32
PREAI
errOviedo-Joekes, Eugenia; Brissette, Suzanne; MacDonald, Scott; Guh, Daphne; Marchand, Kirsten; Jutha, Salima; Harrison, Scott; Janmohamed, Amin; Zhang, Derek Z.; Anis, Aslam H.; Krausz, Michael; Marsh, David C.; Schechter, Martin T.
errShare
errSave